Dienogest/ethinylestradiol extended release - Exeltis

Drug Profile

Dienogest/ethinylestradiol extended release - Exeltis

Alternative Names: LPRI-421

Latest Information Update: 21 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Exeltis
  • Class Alkylated estrogenic steroids; Antiandrogens; Estrenes; Hormonal contraceptives; Norpregnatrienes; Oral contraceptives; Testosterone congeners
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Pregnancy

Most Recent Events

  • 31 Mar 2017 Phase-II clinical trials in Pregnancy (Prevention, In volunteers) in Lithuania (PO) (EudraCT2016-003831-39)
  • 07 Mar 2017 Chemical structure information added
  • 20 Feb 2017 Phase-II clinical trials in Pregnancy (In volunteers, Prevention) in Germany (PO) (EudraCT2016-003830-26)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top